You are welcome to reuse this Cancer Research UK content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are: Web content: Cancer ...

In its fourth year, Camp Breastie offers campers a glamping experience with educational panels capped off by a party called ...

These included samples from the breast (7 of 9 ductal carcinoma in situ), cervix (4 of 4 CIN), colon (5 of 5 adenomatous polyps, 2 of 2 high-grade dysplasias), esophagus (2 of 2 low-grade, 4 of 4 ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for ...

Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situName of all authors as they appear in the published original article: Rong ...

These changes are called 'precancerous' because they can develop into cancers of the cervix, vagina, vulva, anal canal, penis, and head and neck. Infection with other HPV types causes warts in the ...

9. Malignant tumours other than HCC within 5 years prior to screening, except for malignancies with negligible risk of metastasis or death (eg, 5 year OS rate >90%), such as adequately treated in situ ...

The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants ...

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

The American Society of Clinical Oncology (ASCO) first published a technology assessment for the use of chemoprevention agents for breast cancer risk reduction in 1999. 1 ASCO guidelines are updated ...